Selected research
Market Structure
Global Iohexol Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Iohexol Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Iohexol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Iohexol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Iohexol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Iohexol Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Iohexol Injection include GE Healthcare, Imax, BeiLu Pharma and YRPG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Iohexol Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Iohexol Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Iohexol Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iohexol Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Iohexol Injection Segment by Company
GE Healthcare
Imax
BeiLu Pharma
YRPG
Iohexol Injection Segment by Type
350mg I/ml
240mg I/ml
300mg I/ml
Others
Iohexol Injection Segment by Application
Hospitals
Clinics
Iohexol Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iohexol Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Iohexol Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iohexol Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Iohexol Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Iohexol Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Iohexol Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Iohexol Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 350mg I/ml
- 240mg I/ml
- 300mg I/ml
- Others
Applications
- Hospitals
- Clinics
Companies covered
- GE Healthcare
- Imax
- BeiLu Pharma
- YRPG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Iohexol Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Iohexol Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Iohexol Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Iohexol Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Iohexol Injection Market Dynamics
- 2.1 Iohexol Injection Industry Trends
- 2.2 Iohexol Injection Industry Drivers
- 2.3 Iohexol Injection Industry Opportunities and Challenges
- 2.4 Iohexol Injection Industry Restraints
3 Iohexol Injection Market by Manufacturers
- 3.1 Global Iohexol Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Iohexol Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Iohexol Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Iohexol Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Iohexol Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Iohexol Injection Manufacturers, Product Type & Application
- 3.7 Global Iohexol Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Iohexol Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Iohexol Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Iohexol Injection Tier 1, Tier 2, and Tier 3
4 Iohexol Injection Market by Type
- 4.1 Iohexol Injection Type Introduction
- 4.1.1 350mg I/ml
- 4.1.2 240mg I/ml
- 4.1.3 300mg I/ml
- 4.1.4 Others
- 4.2 Global Iohexol Injection Sales by Type
- 4.2.1 Global Iohexol Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Iohexol Injection Sales by Type (2021-2032)
- 4.2.3 Global Iohexol Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Iohexol Injection Revenue by Type
- 4.3.1 Global Iohexol Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Iohexol Injection Revenue by Type (2021-2032)
- 4.3.3 Global Iohexol Injection Revenue Market Share by Type (2021-2032)
5 Iohexol Injection Market by Application
- 5.1 Iohexol Injection Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.2 Global Iohexol Injection Sales by Application
- 5.2.1 Global Iohexol Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Iohexol Injection Sales by Application (2021-2032)
- 5.2.3 Global Iohexol Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Iohexol Injection Revenue by Application
- 5.3.1 Global Iohexol Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Iohexol Injection Revenue by Application (2021-2032)
- 5.3.3 Global Iohexol Injection Revenue Market Share by Application (2021-2032)
6 Global Iohexol Injection Sales by Region
- 6.1 Global Iohexol Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Iohexol Injection Sales by Region (2021-2032)
- 6.2.1 Global Iohexol Injection Sales by Region (2021-2026)
- 6.2.2 Global Iohexol Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Iohexol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Iohexol Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Iohexol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Iohexol Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Iohexol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Iohexol Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Iohexol Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Iohexol Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Iohexol Injection Revenue by Region
- 7.1 Global Iohexol Injection Revenue by Region
- 7.1.1 Global Iohexol Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Iohexol Injection Revenue by Region (2021-2026)
- 7.1.3 Global Iohexol Injection Revenue by Region (2027-2032)
- 7.1.4 Global Iohexol Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Iohexol Injection Revenue (2021-2032)
- 7.2.2 North America Iohexol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Iohexol Injection Revenue (2021-2032)
- 7.3.2 Europe Iohexol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Iohexol Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Iohexol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Iohexol Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Iohexol Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 GE Healthcare
- 8.1.1 GE Healthcare Company Information
- 8.1.2 GE Healthcare Business Overview
- 8.1.3 GE Healthcare Iohexol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 GE Healthcare Iohexol Injection Product Portfolio
- 8.1.5 GE Healthcare Recent Developments
- 8.2 Imax
- 8.2.1 Imax Company Information
- 8.2.2 Imax Business Overview
- 8.2.3 Imax Iohexol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Imax Iohexol Injection Product Portfolio
- 8.2.5 Imax Recent Developments
- 8.3 BeiLu Pharma
- 8.3.1 BeiLu Pharma Company Information
- 8.3.2 BeiLu Pharma Business Overview
- 8.3.3 BeiLu Pharma Iohexol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 BeiLu Pharma Iohexol Injection Product Portfolio
- 8.3.5 BeiLu Pharma Recent Developments
- 8.4 YRPG
- 8.4.1 YRPG Company Information
- 8.4.2 YRPG Business Overview
- 8.4.3 YRPG Iohexol Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 YRPG Iohexol Injection Product Portfolio
- 8.4.5 YRPG Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Iohexol Injection Value Chain Analysis
- 9.1.1 Iohexol Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Iohexol Injection Production Mode & Process
- 9.2 Iohexol Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Iohexol Injection Distributors
- 9.2.3 Iohexol Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst